| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | United States | 5 | |
| #3 | WIPO (World Intellectual Property Organization) | 5 | |
| #4 | Canada | 4 | |
| #5 | EPO (European Patent Office) | 4 | |
| #6 | Israel | 4 | |
| #7 | Brazil | 3 | |
| #8 | Mexico | 3 | |
| #9 | China | 2 | |
| #10 | Republic of Korea | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Steroids | |
| #4 | Organic chemistry methods |
| # | Name | Total Patents |
|---|---|---|
| #1 | Baharaff Allen | 25 |
| #2 | Gorfine Tali | 17 |
| #3 | Mato De La Paz Jose M | 10 |
| #4 | Hayardeny-Nissimoiv Liat | 9 |
| #5 | Allen Baharaff | 8 |
| #6 | Hayardeny-Nissimov Liat | 6 |
| #7 | Halpern Maya | 4 |
| #8 | Tali Gorfine | 4 |
| #9 | Maya Halpern | 4 |
| #10 | Liat Hayardeny-Nissimoiv | 4 |
| Publication | Filing date | Title |
|---|---|---|
| US2020277326A1 | Aramchol salts | |
| WO2020095293A1 | Treatment and inhibition of fibrosis in non-alcoholic fatty liver disease patients | |
| WO2020049556A1 | Combination therapy for the treatment of liver disease | |
| IL266530D0 | Treatment for fibrosis | |
| US2019175619A1 | Treatment of fibrosis, and inhibition of fibrosis in non-alcoholic fatty liver disease patients | |
| KR20190083660A | Inhibition of fibrosis in patients with non-alcoholic fatty liver disease | |
| WO2018051180A1 | Treatment for diastolic dysfunction |